Quantcast

Latest Organ failure Stories

2014-05-29 12:28:41

WASHINGTON, May 29, 2014 /PRNewswire-USNewswire/ -- On May 30(th), nephrologists and kidney patients from across the country will convene in Washington to participate in the Renal Physicians Association's (RPA) annual Capitol Hill Day. Coordinated in collaboration with the American Association of Kidney Patients (AAKP), RPA's Capitol Hill day offers kidney patients and nephrologists the opportunity to advocate on issues impacting the delivery of effective and appropriate kidney disease...

2014-05-29 08:28:45

Heart failure is the second leading cause of hospitalization of Canadians over 65 and responsible for nine per cent of all deaths MONTREAL, May 29, 2014 /CNW/ - Canada's leading cardiologists and other health professionals interested in heart failure are meeting in Montreal this weekend at the Heart Failure Update 2014 meeting to examine the newest developments in heart failure, a condition responsible for nine per cent of all deaths in Canada.(i) The burden of heart failure is...

2014-05-28 16:26:48

ATLANTA, May 28, 2014 /PRNewswire/ -- Arcapita Ventures announced today that CardioMEMS, Inc. has received U.S. FDA (Food and Drug Administration) approval for its Heart Failure Management System. The approval is based upon the results of the CHAMPION (CardioMEMS Heart Sensor Allows Monitoring of Pressure to Improve Outcomes in NYHA Class III Patients) clinical trial which demonstrated a 28% reduction in the primary efficacy endpoint of heart failure hospitalization rates at 6 months,...

2014-05-22 23:16:21

New book tells of an extraordinary comeback from kidney failure to good health. London (PRWEB) May 22, 2014 Adeleke Eniola Oyenusi’s recovery from kidney failure inspired him to write his new book “Living a Normal and Healthy Life after Renal (Kidney) Failure” (published by Trafford Publishing) to encourage and educate other renal patients with little or no knowledge about the condition. “I asked my wife to quickly rush me to the hospital when I became breathless and feared I...

2014-05-19 12:31:37

European Society of Cardiology Worsening symptoms and signs of heart failure in patients admitted to a hospital is a common sign of treatment failure Worsening symptoms and signs of heart failure (WHF) in patients admitted to a hospital is a common sign of treatment failure and can lead to long-term consequences for the patient, including longer length of hospitalization and a higher risk for readmission and death, according to a late-breaking study (RELAX-AHF, PROTECT) presented in...

2014-05-19 11:42:51

European Society of Cardiology Sleeping pills increase the risk of cardiovascular events in heart failure patients by 8-fold, according to research from Japan. The study was presented today at the Heart Failure Congress 2014, held 17-20 May in Athens, Greece. The Congress is the main annual meeting of the Heart Failure Association of the European Society of Cardiology. Dr Masahiko Setoguchi said: "Sleeping problems are a frequent side effect of heart failure and it is common for...

2014-05-15 08:33:06

Completes Enrollment in Phase 2b Clinical Trial of CLP-1001 for Heart Failure SUNNYVALE, Calif., May 15, 2014 /PRNewswire/ -- Sorbent Therapeutics, Inc., a biopharmaceutical company developing therapies for cardiovascular and renal diseases, today announced the closing a $6.5 million tranche in a $15 million Series D financing. Existing investors CMEA Capital, ARCH Venture Partners, Sofinnova Ventures, AgeChem and Novartis Venture Funds participated in the round. Sorbent also...

2014-05-14 16:28:26

RIVER EDGE, N.J., May 14, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today that John C. Houghton, President and Chief Executive Officer, will present at the Third Annual Marcum MicroCap Conference in New York on Thursday, May 29, 2014 at 3:30 p.m. EDT....

2014-05-13 23:16:04

Avail is conducting a phase 1, single dose, parallel group study to evaluate the pharmacokinetics of an experimental drug in subjects with impaired renal function. DeLand, FL (PRWEB) May 13, 2014 *To see if you qualify for this Renal Impairment Clinical Trial in DeLand, visit Avail Clinical Research on the web (http://www.availclinical.com) or contact us directly at (386) 785-2404. There is no cost to participate, no insurance is required, and you may receive compensation for time and...

2014-05-13 16:28:05

RIVER EDGE, N.J., May 13, 2014 /PRNewswire/ -- Nephros, Inc. (OTCQB: NEPH), a commercial stage medical device company that develops and sells high performance liquid purification ultrafilters and an on-line mid-dilution hemodiafiltration system for the treatment of chronic renal failure patients, announced today the first commercial use of its hemodiafiltration ("HDF") system in the United States. As announced in a separate press release today, DaVita Kidney Care, a division of DaVita...


Word of the Day
vermicular
  • Like a worm in form or movement; vermiform; tortuous or sinuous; also, writhing or wriggling.
  • Like the track or trace of a worm; appearing as if worm-eaten; vermiculate.
  • Marked with fine, close-set, wavy or tortuous lines of color; vermiculated.
  • A form of rusticated masonry which is so wrought as to appear thickly indented with worm-tracks.
This word ultimately comes from the Latin 'vermis,' worm.
Related